Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.
Koshrovski-Michael S, Ajamil DR, Dey P, Kleiner R, Tevet S, Epshtein Y, Green Buzhor M, Khoury R, Pozzi S, Shenbach-Koltin G, Yeini E, Woythe L, Blau R, Scomparin A, Barshack I, Florindo HF, Lazar S, Albertazzi L, Amir RJ, Satchi-Fainaro R.
Koshrovski-Michael S, et al. Among authors: woythe l.
Sci Adv. 2024 Dec 13;10(50):eadr4762. doi: 10.1126/sciadv.adr4762. Epub 2024 Dec 13.
Sci Adv. 2024.
PMID: 39671487
Free PMC article.